Improved tumor-targeting MRI contrast agents: Gd(DOTA) conjugates of a cycloalkane-based RGD peptide.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Biochemical and Biophysical Research Communications - BBRC

• Publication date

  2014-12-12

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.bbrc.2014.10.155PMID 25449282
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cyclic RGD Peptides Incorporating Cycloalkanes: Synthesis and Evaluation as PET Radiotracers for Tumor Imaging.

  2014cited by this paper
• RGD-based strategies to target alpha(v) beta(3) integrin in cancer therapy and diagnosis.

  2012cited by this paper
• Integrin Targeted MR Imaging

  2011cited by this paper
• Radiolabeled Cyclic RGD Peptides as Radiotracers for Imaging Tumors and Thrombosis by SPECT

  2011cited by this paper
• Targeted drug delivery to tumors: myths, reality and possibility.

  2011cited by this paper
• Targeting alphavbeta3 integrin: design and applications of mono- and multifunctional RGD-based peptides and semipeptides.

  2010cited by this paper
• 18F-Labeled Galacto and PEGylated RGD Dimers for PET Imaging of αvβ3 Integrin Expression

  2010cited by this paper
• Macromolecules, dendrimers, and nanomaterials in magnetic resonance imaging: the interplay between size, function, and pharmacokinetics.

  2010cited by this paper
• Targeting αvβ3 Integrin: Design and Applications of Mono- and Multifunctional RGD-Based Peptides and Semipeptides

  2010cited by this paper
• Advances in metal-based probes for MR molecular imaging applications.

  2010cited by this paper
• Molecular imaging targeting peptide receptors.

  2009cited by this paper
• Synthesis, characterization, and biological evaluation of integrin alphavbeta3-targeted PAMAM dendrimers.

  2008cited by this paper
• Gd‐DOTA Conjugate of RGD as a Potential Tumor‐Targeting MRI Contrast Agent

  2008cited by this paper
• 68Ga-labeled multimeric RGD peptides for microPET imaging of integrin αvβ3 expression

  2008cited by this paper
• The synthesis and chelation chemistry of DOTA-peptide conjugates.

  2008cited by this paper
• Non-natural amino acids for tumor imaging using positron emission tomography and single photon emission computed tomography

  2008cited by this paper
• αvβ3-integrin imaging: a new approach to characterise angiogenesis?

  2006cited by this paper
• Alphavbeta3-integrin imaging: a new approach to characterise angiogenesis?

  2006cited by this paper
• Strategies for increasing the sensitivity of gadolinium based MRI contrast agents.

  2006cited by this paper
• Quantitative PET imaging of tumor integrin alphavbeta3 expression with 18F-FRGD2.

  2006cited by this paper
• Quantitative PET Imaging of Tumor Integrin αvβ3 Expression with 18F-FRGD2

  2006cited by this paper
• microPET imaging of glioma integrin {alpha}v{beta}3 expression using (64)Cu-labeled tetrameric RGD peptide.

  2005cited by this paper
• Grafting aminocyclopentane carboxylic acids onto the RGD tripeptide sequence generates low nanomolar alphaVbeta3/alphaVbeta5 integrin dual binders.

  2005cited by this paper
• microPET Imaging of Glioma Integrin αvβ3 Expression Using 64Cu-Labeled Tetrameric RGD Peptide

  2005cited by this paper
• Grafting Aminocyclopentane Carboxylic Acids onto the RGD Tripeptide Sequence Generates Low Nanomolar αVβ3/αVβ5 Integrin Dual Binders

  2005cited by this paper
• Crystal Structure of the Extracellular Segment of Integrin αVβ3 in Complex with an Arg-Gly-Asp Ligand

  2002cited by this paper
• Synthesis, in vitro receptor binding, and in vivo evaluation of fluorescein and carbocyanine peptide-based optical contrast agents.

  2002cited by this paper
• Novel receptor-targeted fluorescent contrast agents for in vivo tumor imaging.

  2000cited by this paper
• Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and Applications.

  1999cited by this paper
• Stereoisomeric Peptide Libraries and Peptidomimetics for Designing Selective Inhibitors of the αvβ3 Integrin for a New Cancer Therapy

  1997cited by this paper
• Requirement of vascular integrin alpha v beta 3 for angiogenesis.

  1994cited by this paper

• Early evaluation of anti-angiogenic effects with gadolinium(III) labeled APN/CD13 specific binding peptides magnetic resonance imaging

  2025influential citation
• EGFR-targeted gadolinium contrast agents for enhanced molecular magnetic resonance imaging of tumors

  2025cites this paper
• Magnetic Resonance Imaging Using a Chimeric Anti-Glypican-3 Antibody Conjugated with Gadolinium Selectively Detects Glypican-3-Positive Hepatocellular Carcinoma In Vitro and In Vivo

  2025cites this paper
• Magnetic resonance/fluorescence dual-modality contrast agents targeting αvβ6-overexpressing tumors based on A20FMDV2 peptide as a ligand.

  2023cites this paper
• Design, Synthesis and Binding Affinity Evaluation of Cytochrome P450 1B1 Targeted Chelators.

  2021cites this paper
• Combination of peptides with biological, organic, and inorganic materials for synergistically enhanced diagnostics and therapeutics

  2021cites this paper
• RGD-Peptide Functionalization Affects the In Vivo Diffusion of a Responsive Trimeric MRI Contrast Agent through Interactions with Integrins

  2021cites this paper
• Lanthanide conjugates as versatile instruments for therapy and diagnostics.

  2020cites this paper
• Research on the improvement of the diagnostic effect of machine learning on nuclear magnetic resonance of brain tumors

  2019cites this paper
• Lanthanides: Schiff base complexes, applications in cancer diagnosis, therapy, and antibacterial activity

  2018cites this paper
• Evaluation of methotrexate-conjugated gadolinium(III) for cancer diagnosis and treatment

  2018cites this paper
• evaluation of methotrexate-conjugated gadolinium(iii) for cancer diagnosis and treatment

  2018cites this paper
• evaluation of methotrexate-conjugated gadolinium(iii) for cancer diagnosis and treatment

  2018cites this paper
• An update on nanoparticle-based contrast agents in medical imaging

  2018cites this paper
• Multimodal Hydrogel-Based Platform To Deliver and Monitor Cardiac Progenitor/Stem Cell Engraftment

  2017cites this paper
• Synthesis and Evaluation of a Biocompatible Macromolecular Gadolinium Compound as a Liver-Specific Contrast Agent for MRI

  2017cites this paper
• Synthesis and characterization of 159Gd-doped hydroxyapatite nanorods for bioapplications as theranostic systems

  2016cites this paper
• Improved Pharmacokinetics Following PEGylation and Dimerization of a c(RGD-ACH-K) Conjugate Used for Tumor Positron Emission Tomography Imaging

  2016cites this paper
• Synthesis and characterization of gadolinium-Peptidomimetic complex as an αvβ3 integrin targeted MR contrast agent.

  2015cites this paper
• Hybrid PET/optical imaging of integrin αVβ3 receptor expression using a 64Cu-labeled streptavidin/biotin-based dimeric RGD peptide

  2015cites this paper